Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Corticosteroid for ACS Prevention in SCD
NCT02187445Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of budesonide in acute chest syndrome (ACS), sponsored by Vanderbilt University. Primary endpoint: Acceptability of budesonide inhalation suspension at 6 months. Started Jun 2014; status: completed.
02
Drugs
budesonide
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT02187445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187445.